Optimal use of aromatase inhibitors: to lead or to follow?

J Clin Oncol. 2007 Jul 1;25(19):2639-41. doi: 10.1200/JCO.2007.10.9447. Epub 2007 Jun 11.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Aged
  • Alleles
  • Anastrozole
  • Antineoplastic Agents / pharmacology*
  • Aromatase Inhibitors / pharmacology*
  • Breast Neoplasms / drug therapy*
  • Disease-Free Survival
  • Female
  • Humans
  • Middle Aged
  • Nitriles / pharmacology*
  • Postmenopause
  • Receptors, Estrogen / metabolism
  • Recurrence
  • Tamoxifen / pharmacology*
  • Treatment Outcome
  • Triazoles / pharmacology*

Substances

  • Antineoplastic Agents
  • Aromatase Inhibitors
  • Nitriles
  • Receptors, Estrogen
  • Triazoles
  • Tamoxifen
  • Anastrozole